The short version
- What the evidence isOne real randomized double-blind placebo-controlled trial, and the regimen it tested is not the one a tablet buyer runs.
- What to watchA gout flare, with a hot swollen big toe.
How Cytoflavin works
Four ingredients that sit in one stretch of mitochondrial metabolism: succinic acid feeds electrons directly into complex II, inosine regenerates adenine nucleotides, nicotinamide is the NAD precursor and riboflavin the FAD precursor. That is a more coherent rationale than most combination products manage. It also runs into a problem inside its own lead ingredient — succinate accumulation is what the modern reperfusion-injury literature identifies as the driver of the reactive oxygen species burst when blood returns to ischemic tissue. Fuel and trigger are the same molecule at the same enzyme; which description applies depends on the oxygen state of the tissue.
Four ingredients, and the argument is that they sit in one pathway. Cytoflavin is succinic acid (as meglumine sodium succinate), inosine, nicotinamide and riboflavin.
The mechanistic problem sits inside the lead ingredient. Chouchani 2014 showed that succinate accumulation during ischemia is what drives reperfusion injury — on reoxygenation the accumulated succinate is rapidly oxidized at complex II, driving reverse electron transport and a burst of mitochondrial reactive oxygen species. That is the modern account of why ischemic tissue is damaged when blood returns, and its central actor is the molecule this product supplies.
- Oral
On the goal map: Substrate & fuel availability (Endurance & work capacity)
Research on Cytoflavin8 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: One randomized double-blind placebo-controlled trial in diabetic neuropathy (n=216) which began intravenously; one uncontrolled athlete study.
Human clinical evidence
One real randomized double-blind placebo-controlled trial, and the regimen it tested is not the one a tablet buyer runs. CYLINDER randomized 109 people to the combination and 107 to placebo, aged 45-74 with type 2 diabetes and symptomatic polyneuropathy, and gave it intravenously for 10 days and then orally for 75 (Kharitonova 2022).
Mean Total Symptom Score change at 12 weeks was -2.65 against -1.73 on placebo, p<0.0001 — a between-group difference of 0.92 points on a subjective scale. The authors list a small effect size and subjective outcome assessment among their own limitations, which is more careful than most trials are about themselves.
Correlative data
The athlete study everyone quotes gave it to 30 professional ice hockey players for six weeks against 30 who received nothing, with no randomization, blinding or placebo (Zaborova 2023). Read the body composition result carefully: the untreated group lost weight faster at both time points, and the paper presents that as improved control of weight reduction.
Reviewed alongside Mexidol and the succinate derivatives as antihypoxic metabolic modulators and ergogenic aids in athletes, explicitly in the context of their potential as performance-enhancing drugs (Jedrejko 2024). Its clinical home market is Russian neuroprotection for ischemic stroke (Yagudina 2019).
How the mechanism reads
Four ingredients in one stretch of mitochondrial metabolism: succinate feeds complex II, inosine regenerates adenine nucleotides, nicotinamide is the NAD precursor and riboflavin the FAD precursor.
MechanisticThe mechanistic problem is inside the lead ingredient. Succinate accumulation is what drives the reactive-oxygen burst on reperfusion (Chouchani 2014) — fuel and trigger are the same molecule at the same enzyme, and which description applies depends on the tissue's oxygen state.
MechanisticThe only study that took the combination apart, in mice, found the behavioral protection traced to succinate and inosine and did not depend on their antioxidant activity (Volchegorskii 2013) — which undercuts the antioxidant story the product is sold on.
Experimental, animal or cellPredicted downside nobody has measured: inosine is a purine and ends as urate. No study in this literature reports serum uric acid, over a 75-day oral course.
Mechanistic
Sources
- Kharitonova T, Shvarts YG, Verbovoy AF, Orlova NS, Puzyreva VP, Strokov IA. Efficacy and safety of the combined metabolic medication containing inosine, nicotinamide, riboflavin and succinic acid for the treatment of diabetic neuropathy (CYLINDER). BMJ Open Diabetes Research & Care 2022 · PMID 35680173
- Zaborova V, Kurshev V, Kryuchkova K, et al. Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin). Biology (Basel) 2023 · PMID 36829493
- Volchegorskii IA, Rassokhina LM, Ermakova SG, Miroshnichenko IIu. [Protective effect of cytoflavin and its components in mice with acute alloxan intoxication]. Eksperimentalnaia i Klinicheskaia Farmakologiia 2013 [Russian] · PMID 23762986
- Jędrejko K, Catlin O, Stewart T, Muszyńska B. Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti-ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs. Drug Testing and Analysis 2024 · PMID 38403950
- Chouchani ET, Pell VR, Gaude E, Aksentijević D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord ENJ, Smith AC, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014;515(7527):431-435 · PMID 25383517
- Yagudina RI. [Pharmacoeconomic analysis of the neuroprotective medicines in the treatment of ischemic stroke]. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova 2019 [Russian] · PMID 31464291
Cytoflavin safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Gout or a high uric acid, since inosine is converted to uric acid.
- Kidney stones of uric acid type.
- Significant kidney impairment, where purine and succinate handling is slower.
- Pregnancy or under 18, with no safety data on this four-part mix.
What’s expected
- Bright yellow urine from riboflavin.
- Mild stomach upset from succinic acid.
- A small rise in uric acid.
Watch for
- A gout flare, with a hot swollen big toe.
- Flank pain from a stone.
- Flushing or an itchy rash.
Labs that tell you it’s working
- Uric Acid: the concrete cost of an inosine load.
- Homocysteine: heavy nicotinamide use consumes methyl groups and can raise it.
- Comprehensive Metabolic Panel: kidney function for purine clearance.
Succinate, inosine, nicotinamide and riboflavin: complex II feeding, adenine nucleotide recycling, NAD and FAD precursors; purine load is the risk. PMID 35680173 PMID 25383517
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Cytoflavin FAQ3 common questions
- Is Cytoflavin approved for human use?
- No. Cytoflavin is a research compound.
- Which labs show whether it's doing anything?
- Uric Acid; Homocysteine; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Cytoflavin: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



